Biotech · Private company
Averitas Pharma, Inc.
Track this companyFree. Adds Averitas Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- capsaicin 0.04% topical systemPhase 3 · Post Surgical Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- Qutenza (capsaicin) 8% topical systemPhase 3 · Post Surgical Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- Capsaicin 8%Peripheral Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot StudyEARLY_PHASE1 · RECRUITING · started Dec 11, 2025ClinicalTrials.gov NCT06744816 · fetched Nov 12, 2026
- Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral NeuropathyACTIVE_NOT_RECRUITING · started Mar 14, 2025ClinicalTrials.gov NCT06495424 · fetched Nov 12, 2026
- Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral RadiculopathyENROLLING_BY_INVITATION · started Mar 13, 2025ClinicalTrials.gov NCT06540456 · fetched Nov 12, 2026
- Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After SurgeryPHASE3 · COMPLETED · started Jul 13, 2021ClinicalTrials.gov NCT04967664 · fetched Nov 12, 2026